University of the Pacific Thomas J. Long School of Pharmacy
The skill set and clinical experience gained from our PharmD program open new doors to the many settings where pharmacists play a key role -- from hospitals to pharmaceutical research and development. Through each component of our PharmD curriculum, students learn how to become a pharmacist who leads with excellence.
From the first semester, students develop patient-care skills that are integrated throughout the PharmD curriculum, exposing them to the administrative, pharmaceutical, social, behavioral and clinical science aspects of the field of pharmacy. This combination allows students to develop a solid foundation of practical training by gaining patient care experience across a wide variety of settings.
The School is home to a robust interprofessional education (IPE) curriculum that supports PharmD students. Through IPE, students engage in case-based learning, simulations, peer teaching, telehealth simulations and innovative gaming techniques such as escape room scenarios. They also apply teamwork skills and learned concepts in interprofessional practice experiences during their Introductory Pharmacy Practice Experiences (IPPE) and Advanced Pharmacy Practice Experiences (APPE).
The Thomas J. Long School of Pharmacy is committed to the success of our students. To ensure that each of our PharmD graduates are prepared for their careers, we offer a first-of-its- kind, immersive three-week residential California Practice Standards and Jurisprudence Examination (CPJE) and North American Pharmacist Licensure Exam (NAPLEX) preparatory program.
This comprehensive program is designed to build on students' strengths through targeted practice sessions and engaging reviews and complements other available resources. In their third year, all students also complete 'Rx Prep' to begin early preparation for licensure exams.
At Pacific, students have the opportunity to work alongside faculty members on cutting-edge research. Current projects focus on novel drug delivery systems, innovative drug design and forward- thinking approaches to patient care. Our faculty have also earned international recognition for their research on diabetes and consumer products.
While pursuing their PharmD, students can customize their education through two distinct and dynamic pathways: clinical pharmacology and entrepreneurship.
The clinical pharmacology pathway prepares students with a comprehensive understanding of clinical drug development and equips them to contribute to evidence-based decision-making in drug therapy and development.
The entrepreneurship pathway provides future scientists with a strong foundation in pharmaceutical business operations and the entrepreneurial skills needed to launch and lead ventures focused on novel drug products and medical devices.
The School's dual-degree programs combine the clinical training of the PharmD with immersive research through the Pharmaceutical and Chemical Sciences Program, preparing PharmD/MS and PharmD/PhD graduates for high- demand roles in industry and academia.
Learn more and apply today at Pacific.edu/PharmD
University of the Pacific
Thomas J. Long School of Pharmacy
Berit Gundersen, PharmD
1851
1955
530
Doctor of Pharmacy (PharmD)
Pathways:Clinical pharmacologyEntrepreneurship
Dual-degrees:PharmD/MSPharmD/PhD
3 years
In 2024, following a rigorous review, the Accreditation Council for Pharmacy Education (ACPE) granted Pacific's doctor of pharmacy program an eight-year reaccreditation.
2025-26: $235,784
Final application deadline: June 6, 2025
Tony Williams, Director of RecruitmentOffice of Pharmacy Admission209.932.3600pharmdadmission@pacific.edu Pacific.edu/PharmD
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
11 hours ago
- Business Wire
Bio-Rad to Host Droplet Digital PCR Webinar on Tuesday, August 26, 2025
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced today that the company's management will host an informational webinar on Bio-Rad's Droplet Digital™ PCR (ddPCR™) product portfolio on Tuesday, August 26, 2025, at 10:00 AM Pacific Time (1:00 PM Eastern Time). The event will include a presentation followed by a Q&A session with analysts hosted by Bio-Rad's President and Chief Operating Officer Jon DiVincenzo and Chief Financial Officer Roop K. Lakkaraju. To participate, dial (800) 715-9871 within the U.S. or (+1) (646) 307-1963 outside the U.S., access code: 9562470. A live webcast of the event, and the accompanying slide presentation, will also be available in the "Investor Relations" section of the company's website under "Events & Presentations" at A replay of the webcast will be available for up to a year. About Bio-Rad Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 7,500 employees, and $2.6 billion in revenues in 2024. Our customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety and environmental quality laboratories. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit
Business Wire
a day ago
- Business Wire
Vistagen to Report Fiscal Year 2026 First Quarter Results and Host Corporate Update Conference Call on August 7, 2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today announced it will host a conference call and webcast on Thursday, August 7, 2025, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to report results for its fiscal year 2026 first quarter ended June 30, 2025, and provide a corporate update. The conference call is being webcast live, and a link can be found under ' Events ' in the Investors section of the Company's website. Please click on the webcast link and follow the prompts for registration and access at least 10 minutes before the call. The webcast will be archived on Vistagen's website shortly after the call and will be available for at least 90 days. For participants interested in participating in the call via dial-in, please follow the link below to pre-register. After registering, you will be provided with access details via email. About Vistagen Headquartered in South San Francisco, CA, Vistagen (Nasdaq: VTGN) is a late clinical-stage biopharmaceutical company leveraging a deep understanding of nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines. Pherines specifically and selectively bind as agonists on peripheral receptors on human nasal chemosensory neurons and are designed to rapidly activate olfactory bulb-to-brain neurocircuits believed to regulate brain areas involved in behavior and autonomic nervous system activity. They are designed to achieve therapeutic benefits without requiring absorption into the blood or uptake into the brain, giving them the potential to be a safer alternative to other pharmacological options if successfully developed and approved. Vistagen is passionate about developing transformative treatment options to improve the lives of individuals underserved by the current standard of care for multiple highly prevalent indications, including social anxiety disorder, major depressive disorder, and multiple women's health conditions, including vasomotor symptoms (hot flashes) associated with menopause. Connect at
Yahoo
3 days ago
- Yahoo
6 Medications That Don't Mix Well with Your Vitamin D Supplement, According to Pharmacists
Reviewed by Dietitian Kelly Plowe, M.S., RDKey Points Vitamin D is a popular supplement, but it can have harmful interactions with various medications. High blood pressure and seizure medications are just some of the drugs that may not mix well. Talk with your pharmacist about any medications you're taking that may interact with vitamin need vitamin D for our immune health, building and maintaining bone density and even reducing inflammation. But it's challenging to eat enough vitamin D through food alone. And even though it's synthesized in the skin via sun exposure, it's often not enough. Perhaps that's why about a third of Americans are turning to vitamin D supplements to help meet their daily needs. Vitamin D supplements help to fill the gaps, but that can come at a cost if they're taken with certain medications. 'Like any supplement, vitamin D should be used with guidance to avoid interactions and ensure safety,' says Lauren Smith, Pharm.D. Learn more about these six medications that interact with vitamin D supplements. Thiazide Diuretics High blood pressure is common in the U.S., with close to half of American adults living with the condition. If you're one of the many with high blood pressure, then you may be prescribed a drug from a group known as thiazide diuretics, such as hydrochlorothiazide. In addition to managing fluid retention and blood pressure, thiazide diuretics also cause the body to absorb and retain calcium. 'Adding vitamin D on top of that can sometimes raise calcium in the body to unsafe levels, which may cause nausea, confusion or irregular heart rhythms,' says Smith. Corticosteroids Corticosteroids like prednisone are prescribed for a variety of conditions, such as inflammatory disorders and autoimmune diseases. They can also interact with vitamin D supplements because they may reduce their effectiveness. 'Long-term use [of corticosteroids] can make it harder for your body to use vitamin D, which means you may not receive enough calcium,' says Smith. 'Over time this increases the risk for weakened bones.' Smith says that it may be beneficial to take a vitamin D supplement when prescribed corticosteroids but emphasizes to only do so under the care of a health care professional. Antiseizure Medications Antiseizure medications like phenytoin or phenobarbital are prescribed to treat seizures and, in some cases, may be used as a sedative. These types of medications have been linked to vitamin D deficiency and lower blood calcium levels, which can negatively impact bone density. 'These medications cause your body to break down vitamin D faster, making it less effective and possibly leading to weaker bones over time,' says Smith. Cardiac Glycosides 'Vitamin D and calcium go hand in hand, as vitamin D allows for the absorption of calcium into the body,' says Joseph Walter, Pharm.D., an ambulatory care pharmacist. 'As a result, it can increase calcium levels.' This increase in calcium can cause complications if you're taking cardiac glycosides, like digoxin, which are used to treat heart failure, atrial fibrillation, and arrhythmias—all conditions that affect the heart's rhythm., 'High vitamin D intake can raise calcium levels, increasing the risk of digoxin toxicity, which can cause serious heart rhythm problems,' says Smith. Lipase Inhibitors Lipase inhibitors, such as orlistat, are drugs that reduce the absorption of fat from food. Because vitamin D is a fat-soluble vitamin and requires fat in the diet for optimal absorption, a side effect of orlistat can be a reduction in vitamin D absorption from supplements. Walter recommends separating when you take orlistat and vitamin D supplements by at least two hours. Bile Acid Sequestrants High cholesterol affects approximately 20% of the American population, and if you fall into this category, then you may be prescribed bile acid sequestrants to help manage the condition. These medications can interact with vitamin D supplements through their effect on vitamin D absorption. Walter recommends spacing out the bile acid sequestrants by taking vitamin D either one to four hours before or four to six hours after taking the prescribed medication. Our Expert Take Vitamin D supplements are a popular addition to the health routine of many Americans; however, they may interact with many commonly prescribed medications. 'If you are uncertain if you can take vitamin D with any of your medications, I recommend speaking with your doctor or pharmacist,' says Walter. 'Your pharmacist will have a list of all your medications and will be able to run a drug interaction check to offer the best recommendation regarding vitamin D supplementation.' We've shared commonly prescribed drugs that interact with vitamin D supplements, but keep in mind that this list is not exhaustive. You should work with your pharmacist to identify any medications you're taking that may cause an interaction with supplements, including vitamin D. 'As one of the most accessible health care professionals, pharmacists are perfectly positioned to assist with your medication and supplement needs,' says Walter. Read the original article on EATINGWELL
